Aldeyra Therapeutics amends IPO

Aldeyra again amended its IPO on NASDAQ and now plans to sell 1.2 million shares at $10-$12. Last month, Aldeyra (formerly Aldexa Therapeutics Inc.) amended the offering to 2.3 million shares at the ...